Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in term and near-term newborns. Its role in the management of persistent pulmonary hypertension in preterm infants is not clear. Although guidelines do not exist. some studies have shown that iNO could be used as a rescue therapy in preterm neon... https://parisnaturalfoodes.shop/product-category/pre-workout-energizer/